Edwards Lifesciences initiated at UBS

Edwards Lifesciences initiated with a Neutral at UBS. UBS analyst Matthew Taylor initiated Edwards Lifesciences with a Neutral rating and $165 price target.
https://thefly.com/landingPageNews.php?id=2828785